Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Maria Raho

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 22, 2023
Is blood pTau a reliable indicator of the CSF status? A narrative reviewAnnibale Antonioni, Emanuela Maria Raho, Francesco Di Lorenzo
Expert Review of Neurotherapeutics|February 6, 2025
Frontotemporal dementia. How to deal with its diagnostic complexity?Annibale Antonioni, Emanuela Maria Raho, Enrico Granieri, et al.
Neuroscience and Biobehavioral Reviews|July 28, 2024
The cerebellum and the Mirror Neuron System: A matter of inhibition? From neurophysiological evidence to neuromodulatory implications. A narrative reviewAnnibale Antonioni, Emanuela Maria Raho, Sofia Straudi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 14, 2024
A new perspective on positive symptoms: expression of damage or self-defence mechanism of the brain?Annibale Antonioni, Emanuela Maria Raho, Mariachiara Sensi, et al.
Journal of Neurology|March 6, 2025
Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysisAnnibale Antonioni, Emanuela Maria Raho, Francesco Di Lorenzo, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 17, 2025
Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum: A systematic review and meta-analysisAnnibale Antonioni, Emanuela Maria Raho, Lamberto Manzoli, et al.
Neuroscience and Biobehavioral Reviews|May 5, 2025
The cerebellum in frontotemporal dementia: From neglected bystander to potential neuromodulatory target. A narrative reviewAnnibale Antonioni, Emanuela Maria Raho, Danny Adrian Spampinato, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Case Report: A Case of Creutzfeldt-Jakob Heidenhain Variant Simulating PRESAnnibale Antonioni, Emanuela Maria Raho, Andrea Gozzi, et al.
Movement Disorders Clinical Practice|July 15, 2025
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized StudyFabiana Colucci, Andrea Gozzi, Pietro Antenucci, et al.
Scientific Reports|February 10, 2025
Time perception in cerebellar and basal ganglia stroke patientsAnnibale Antonioni, Emanuela Maria Raho, Mariagrazia Capizzi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 22, 2023
Is blood pTau a reliable indicator of the CSF status? A narrative reviewAnnibale Antonioni, Emanuela Maria Raho, Francesco Di Lorenzo
Expert Review of Neurotherapeutics|February 6, 2025
Frontotemporal dementia. How to deal with its diagnostic complexity?Annibale Antonioni, Emanuela Maria Raho, Enrico Granieri, et al.
Neuroscience and Biobehavioral Reviews|July 28, 2024
The cerebellum and the Mirror Neuron System: A matter of inhibition? From neurophysiological evidence to neuromodulatory implications. A narrative reviewAnnibale Antonioni, Emanuela Maria Raho, Sofia Straudi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 14, 2024
A new perspective on positive symptoms: expression of damage or self-defence mechanism of the brain?Annibale Antonioni, Emanuela Maria Raho, Mariachiara Sensi, et al.
Journal of Neurology|March 6, 2025
Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysisAnnibale Antonioni, Emanuela Maria Raho, Francesco Di Lorenzo, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 17, 2025
Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum: A systematic review and meta-analysisAnnibale Antonioni, Emanuela Maria Raho, Lamberto Manzoli, et al.
Neuroscience and Biobehavioral Reviews|May 5, 2025
The cerebellum in frontotemporal dementia: From neglected bystander to potential neuromodulatory target. A narrative reviewAnnibale Antonioni, Emanuela Maria Raho, Danny Adrian Spampinato, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Case Report: A Case of Creutzfeldt-Jakob Heidenhain Variant Simulating PRESAnnibale Antonioni, Emanuela Maria Raho, Andrea Gozzi, et al.
Movement Disorders Clinical Practice|July 15, 2025
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized StudyFabiana Colucci, Andrea Gozzi, Pietro Antenucci, et al.
Scientific Reports|February 10, 2025
Time perception in cerebellar and basal ganglia stroke patientsAnnibale Antonioni, Emanuela Maria Raho, Mariagrazia Capizzi, et al.
Pageof 2